NEW YORK STATE COMMON RETIREMENT FUND - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 103 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$96
+1820.0%
9,959
+1860.4%
0.00%
Q2 2023$5
-94.0%
508
-95.2%
0.00%
Q1 2023$83
-26.5%
10,608
-36.8%
0.00%
Q4 2022$113
-100.0%
16,787
-0.2%
0.00%
Q3 2022$244,000
+47.9%
16,819
+0.4%
0.00%
Q2 2022$165,000
-33.5%
16,755
-0.3%
0.00%
Q1 2022$248,000
+47.6%
16,810
+32.7%
0.00%
Q4 2021$168,000
-51.7%
12,663
-36.5%
0.00%
Q3 2021$348,000
-64.7%
19,947
-51.5%
0.00%
-100.0%
Q2 2021$985,000
+13.9%
41,096
+22.1%
0.00%0.0%
Q1 2021$865,000
+279.4%
33,659
+180.5%
0.00%
Q4 2020$228,000
+51.0%
12,0000.0%0.00%
Q3 2020$151,000
+4.1%
12,0000.0%0.00%
Q2 2020$145,000
+57.6%
12,0000.0%0.00%
Q1 2020$92,000
-57.0%
12,0000.0%0.00%
Q4 2019$214,000
+54.0%
12,0000.0%0.00%
Q3 2019$139,000
-47.7%
12,0000.0%0.00%
Q2 2019$266,00012,0000.00%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,719,576$25,679,00012.37%
Vivo Capital, LLC 1,618,296$30,731,0001.37%
Opaleye Management Inc. 470,203$8,929,0001.17%
INTERWEST VENTURE MANAGEMENT CO 388,766$7,383,0000.92%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 177,433$3,369,0000.92%
Ikarian Capital, LLC 1,063,961$20,204,0000.89%
Ghost Tree Capital, LLC 200,000$3,798,0000.85%
Logos Global Management LP 490,000$9,305,0000.80%
Eventide Asset Management 1,680,000$31,903,0000.49%
Affinity Asset Advisors, LLC 45,000$855,0000.45%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders